Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1986 1
1988 1
1989 2
1990 3
1994 1
1995 2
1996 4
1997 3
1998 2
1999 1
2001 1
2002 3
2003 3
2004 3
2005 7
2006 5
2007 1
2008 1
2010 2
2011 7
2012 3
2013 3
2014 1
2015 6
2016 9
2017 7
2018 8
2019 6
2020 7
2021 5
2022 3
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Identification of actionable targets for breast cancer intervention using a diversity outbred mouse model.
Jacob JB, Wei KC, Bepler G, Reyes JD, Cani A, Polin L, White K, Kim S, Viola N, McGrath J, Guastella A, Yin C, Mi QS, Kidder BL, Wagner KU, Ratner S, Phillips V, Xiu J, Parajuli P, Wei WZ. Jacob JB, et al. Among authors: polin l. iScience. 2023 Mar 2;26(4):106320. doi: 10.1016/j.isci.2023.106320. eCollection 2023 Apr 21. iScience. 2023. PMID: 36968078 Free PMC article.
ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe.
Heyza JR, Ekinci E, Lindquist J, Lei W, Yunker C, Vinothkumar V, Rowbotham R, Polin L, Snider NG, Van Buren E, Watza D, Back JB, Chen W, Mamdani H, Schwartz AG, Turchi JJ, Bepler G, Patrick SM. Heyza JR, et al. Among authors: polin l. NAR Cancer. 2023 Jan 11;5(1):zcac045. doi: 10.1093/narcan/zcac045. eCollection 2023 Mar. NAR Cancer. 2023. PMID: 36644397 Free PMC article.
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis.
Hurrish KH, Su Y, Patel S, Ramage CL, Carter JL, Edwards H, Buck SA, Wiley SE, Hüttemann M, Polin L, Kushner J, Dzinic SH, White K, Bao X, Li J, Yang J, Boerner J, Hou Z, Al-Atrash G, Konoplev SN, Busquets J, Tiziani S, Matherly LH, Taub JW, Konopleva M, Ge Y, Baran N. Hurrish KH, et al. Among authors: polin l. Res Sq [Preprint]. 2023 Apr 28:rs.3.rs-2843025. doi: 10.21203/rs.3.rs-2843025/v1. Res Sq. 2023. PMID: 37162954 Free PMC article. Updated. Preprint.
Professor Samuel C. Brooks, Jr., Ph.D. (1928-2019).
Polin LA, Shekhar M. Polin LA, et al. Cancer Metastasis Rev. 2020 Mar;39(1):331-332. doi: 10.1007/s10555-020-09861-2. Cancer Metastasis Rev. 2020. PMID: 32180103 No abstract available.
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro.
Hurrish KH, Su Y, Patel S, Ramage CL, Zhao J, Temby BR, Carter JL, Edwards H, Buck SA, Wiley SE, Hüttemann M, Polin L, Kushner J, Dzinic SH, White K, Bao X, Li J, Yang J, Boerner J, Hou Z, Al-Atrash G, Konoplev SN, Busquets J, Tiziani S, Matherly LH, Taub JW, Konopleva M, Ge Y, Baran N. Hurrish KH, et al. Among authors: polin l. Biochem Pharmacol. 2024 Feb;220:115981. doi: 10.1016/j.bcp.2023.115981. Epub 2023 Dec 10. Biochem Pharmacol. 2024. PMID: 38081370
Omeprazole Inhibits Glioblastoma Cell Invasion and Tumor Growth.
Jin UH, Michelhaugh SK, Polin LA, Shrestha R, Mittal S, Safe S. Jin UH, et al. Among authors: polin la. Cancers (Basel). 2020 Jul 28;12(8):2097. doi: 10.3390/cancers12082097. Cancers (Basel). 2020. PMID: 32731514 Free PMC article.
116 results